🎉 M&A multiples are live!
Check it out!

Lumibird Valuation Multiples

Discover revenue and EBITDA valuation multiples for Lumibird and similar public comparables like Clarity Pharmaceuticals, CurveBeam AI, and Australian Clinical Labs.

Lumibird Overview

About Lumibird

Lumibird, formerly Quantel SA is an enterprise engaged in the designing, manufacturing, and sale of scientific laser solutions. Scientific and industrial applications lasers used by research laboratories in the study of material, cleaning lasers, marking, measurement, and others. whereas, Medical applications include specialized lasers for ophthalmology, dermatology, and esthetics. The company generates a majority of its revenue from the scientific and industrial applications.


Founded

1970

HQ

France
Employees

1.1K+

Website

quantel.fr

Financials

LTM Revenue $228M

LTM EBITDA $37.0M

EV

$269M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Lumibird Financials

Lumibird has a last 12-month revenue of $228M and a last 12-month EBITDA of $37.0M.

In the most recent fiscal year, Lumibird achieved revenue of $222M and an EBITDA of $29.7M.

Lumibird expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Lumibird valuation multiples based on analyst estimates

Lumibird P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $209M $222M XXX XXX XXX
Gross Profit $115M $130M XXX XXX XXX
Gross Margin 55% 59% XXX XXX XXX
EBITDA $35.1M $29.7M XXX XXX XXX
EBITDA Margin 17% 13% XXX XXX XXX
Net Profit $14.9M $12.2M XXX XXX XXX
Net Margin 7% 5% XXX XXX XXX
Net Debt $8.3M $46.2M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Lumibird Stock Performance

As of April 15, 2025, Lumibird's stock price is EUR 9 (or $10).

Lumibird has current market cap of EUR 204M (or $219M), and EV of EUR 250M (or $269M).

See Lumibird trading valuation data

Lumibird Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$269M $219M XXX XXX XXX XXX $0.36

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Lumibird Valuation Multiples

As of April 15, 2025, Lumibird has market cap of $219M and EV of $269M.

Lumibird's trades at 1.2x LTM EV/Revenue multiple, and 7.3x LTM EBITDA.

Analysts estimate Lumibird's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Lumibird and 10K+ public comps

Lumibird Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $269M XXX XXX XXX
EV/Revenue 1.2x XXX XXX XXX
EV/EBITDA 9.1x XXX XXX XXX
P/E 28.6x XXX XXX XXX
P/E/Growth 0.5x XXX XXX XXX
EV/FCF -51.3x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Lumibird Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Lumibird Valuation Multiples

Lumibird's NTM/LTM revenue growth is 8%

Lumibird's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Lumibird's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Lumibird's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Lumibird and other 10K+ public comps

Lumibird Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 6% XXX XXX XXX XXX
EBITDA Margin 13% XXX XXX XXX XXX
EBITDA Growth -15% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 22% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 53% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Lumibird Public Comps

See public comps and valuation multiples for Medical Imaging & Diagnostics and Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Australian Clinical Labs XXX XXX XXX XXX XXX XXX
Clarity Pharmaceuticals XXX XXX XXX XXX XXX XXX
CurveBeam AI XXX XXX XXX XXX XXX XXX
Cyclopharm XXX XXX XXX XXX XXX XXX
Healius XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Lumibird M&A and Investment Activity

Lumibird acquired  XXX companies to date.

Last acquisition by Lumibird was  XXXXXXXX, XXXXX XXXXX XXXXXX . Lumibird acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Lumibird

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Lumibird

When was Lumibird founded? Lumibird was founded in 1970.
Where is Lumibird headquartered? Lumibird is headquartered in France.
How many employees does Lumibird have? As of today, Lumibird has 1.1K+ employees.
Who is the CEO of Lumibird? Lumibird's CEO is Mr. Marc Le Flohic.
Is Lumibird publicy listed? Yes, Lumibird is a public company listed on PAR.
What is the stock symbol of Lumibird? Lumibird trades under LBIRD ticker.
When did Lumibird go public? Lumibird went public in 1997.
Who are competitors of Lumibird? Similar companies to Lumibird include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm.
What is the current market cap of Lumibird? Lumibird's current market cap is $219M
What is the current revenue of Lumibird? Lumibird's last 12-month revenue is $228M.
What is the current EBITDA of Lumibird? Lumibird's last 12-month EBITDA is $37.0M.
What is the current EV/Revenue multiple of Lumibird? Current revenue multiple of Lumibird is 1.2x.
What is the current EV/EBITDA multiple of Lumibird? Current EBITDA multiple of Lumibird is 7.3x.
What is the current revenue growth of Lumibird? Lumibird revenue growth between 2023 and 2024 was 6%.
Is Lumibird profitable? Yes, Lumibird is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.